201 related articles for article (PubMed ID: 17442342)
1. Analyzing the "degree of humanness" of antibody sequences.
Abhinandan KR; Martin AC
J Mol Biol; 2007 Jun; 369(3):852-62. PubMed ID: 17442342
[TBL] [Abstract][Full Text] [Related]
2. A molecular immunology approach to antibody humanization and functional optimization.
Lazar GA; Desjarlais JR; Jacinto J; Karki S; Hammond PW
Mol Immunol; 2007 Mar; 44(8):1986-98. PubMed ID: 17079018
[TBL] [Abstract][Full Text] [Related]
3. The humanness of macaque antibody sequences.
Thullier P; Huish O; Pelat T; Martin AC
J Mol Biol; 2010 Mar; 396(5):1439-50. PubMed ID: 20043919
[TBL] [Abstract][Full Text] [Related]
4. Design of humanized antibodies: from anti-Tac to Zenapax.
Tsurushita N; Hinton PR; Kumar S
Methods; 2005 May; 36(1):69-83. PubMed ID: 15848076
[TBL] [Abstract][Full Text] [Related]
5. SDR grafting--a new approach to antibody humanization.
Kashmiri SV; De Pascalis R; Gonzales NR; Schlom J
Methods; 2005 May; 36(1):25-34. PubMed ID: 15848072
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of human antibodies: a detailed and unfinished tapestry of immunoglobulin gene products.
Ramsland PA; Farrugia W
J Mol Recognit; 2002; 15(5):248-59. PubMed ID: 12447901
[TBL] [Abstract][Full Text] [Related]
7. SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity.
Gonzales NR; Padlan EA; De Pascalis R; Schuck P; Schlom J; Kashmiri SV
Mol Immunol; 2004 Jul; 41(9):863-72. PubMed ID: 15261458
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of engineered antibodies.
Hwang WY; Foote J
Methods; 2005 May; 36(1):3-10. PubMed ID: 15848070
[TBL] [Abstract][Full Text] [Related]
9. Engineering antibodies for stability and efficient folding.
Honegger A
Handb Exp Pharmacol; 2008; (181):47-68. PubMed ID: 18071941
[TBL] [Abstract][Full Text] [Related]
10. Human IgG1 Cgamma1 domain is crucial for the bioactivity of the engineered anti-CD20 antibodies.
Geng S; Feng J; Li Y; Kang X; Sun Y; Gu X; Huang Y; Chang H; Shen BF
Cell Mol Immunol; 2007 Apr; 4(2):121-5. PubMed ID: 17484806
[TBL] [Abstract][Full Text] [Related]
11. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
Meli G; Visintin M; Cannistraci I; Cattaneo A
J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
[TBL] [Abstract][Full Text] [Related]
12. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody humanness score and its applications.
Gao SH; Huang K; Tu H; Adler AS
BMC Biotechnol; 2013 Jul; 13():55. PubMed ID: 23826749
[TBL] [Abstract][Full Text] [Related]
14. Modifying antibody specificity by chain shuffling of V / V between antibodies with related specificities.
Christensen PA; Danielczyk A; Ravn P; Larsen M; Stahn R; Karsten U; Goletz S
Scand J Immunol; 2009 Jan; 69(1):1-10. PubMed ID: 19140871
[TBL] [Abstract][Full Text] [Related]
15. Structure-function relationships of the variable domains of monoclonal antibodies approved for cancer treatment.
Magdelaine-Beuzelin C; Kaas Q; Wehbi V; Ohresser M; Jefferis R; Lefranc MP; Watier H
Crit Rev Oncol Hematol; 2007 Dec; 64(3):210-25. PubMed ID: 17624800
[TBL] [Abstract][Full Text] [Related]
16. Engineering of therapeutic antibodies to minimize immunogenicity and optimize function.
Presta LG
Adv Drug Deliv Rev; 2006 Aug; 58(5-6):640-56. PubMed ID: 16904789
[TBL] [Abstract][Full Text] [Related]
17. In silico analysis of the structure of variable domains of mouse single-chain antibodies specific to the human recombinant interferon beta1b.
Flyak AI; Pavlova MV; Gilchuk PV
Tsitol Genet; 2009; 43(1):54-60. PubMed ID: 19663316
[TBL] [Abstract][Full Text] [Related]
18. Immunological detection of in vitro formed phosphatidylethanol--an alcohol biomarker--with monoclonal antibodies.
Nissinen AE; Mäkelä SM; Vuoristo JT; Liisanantti MK; Hannuksela ML; Hörkkö S; Savolainen MJ
Alcohol Clin Exp Res; 2008 Jun; 32(6):921-8. PubMed ID: 18445103
[TBL] [Abstract][Full Text] [Related]
19. Human antibodies from transgenic animals.
Lonberg N
Nat Biotechnol; 2005 Sep; 23(9):1117-25. PubMed ID: 16151405
[TBL] [Abstract][Full Text] [Related]
20. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
Narayanan A; Sellers BD; Jacobson MP
J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
